SCHEMBL2660074

SCHEMBL2660074

NC(=O)c1ccccc1Cc1nnn[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
TSHR P16473 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPT P10636 1/20 0.37
PARP1 P09874 2/20 0.36
CSNK1A1 P48729 2/20 0.36
DYRK1B Q9Y463 2/20 0.36
PLK4 O00444 1/20 0.36
CHEK1 O14757 1/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
MAP4K4 O95819 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
FGFR1 P11362 1/20 0.36
PDGFRA P16234 1/20 0.36
LTK P29376 1/20 0.36
KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7134588 0.76 TSHR (0.54) ALDH1A1KDM4ETSHRHPGDHSD17B10
SCHEMBL9057228 0.76 AR (0.43) ALDH1A1SMN1; SMN2AR
SCHEMBL7822927 0.76 TAAR1 (0.41) TSHRMEN1KMT2A
SCHEMBL3145757 0.76 HSPA5 (0.52) TSHRMAPT
SCHEMBL6785579 0.75 KDM4E (0.34) ALDH1A1KDM4ETSHRHPGDHSD17B10
SCHEMBL4796619 0.75 BCAT2 (0.36) PARP1CSNK1A1DYRK1BCHEK1BCAT2
SCHEMBL8015701 0.75 KEAP1 (0.40) KDM4EHSD17B10PARP1SMN1; SMN2
SCHEMBL16401656 0.74 ALDH1A1 (0.35) ALDH1A1KDM4ETSHRHPGDHSD17B10
SCHEMBL7654900 0.73 PARP1 (0.33) ALDH1A1KDM4ETSHRHPGDHSD17B10
SCHEMBL9822781 0.73 CA1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957068-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Eli Lilly & Company (US) 2008-08-20 EP claimed
WO-2007120270-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-10-25 WO claimed
WO-2015161011-A1 BENZAMIDE CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2015-10-22 WO disclosed
EP-1957068-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Eli Lilly & Company (US) 2008-08-20 EP disclosed
WO-2007120270-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-10-25 WO disclosed